LIANTONIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.241
AS - Asia 3.200
EU - Europa 1.989
SA - Sud America 802
AF - Africa 117
OC - Oceania 5
Totale 13.354
Nazione #
US - Stati Uniti d'America 7.126
SG - Singapore 1.355
CN - Cina 730
BR - Brasile 654
HK - Hong Kong 394
IT - Italia 375
SE - Svezia 291
RU - Federazione Russa 249
DE - Germania 219
VN - Vietnam 215
FR - Francia 203
FI - Finlandia 174
UA - Ucraina 167
GB - Regno Unito 136
IN - India 100
BD - Bangladesh 82
ID - Indonesia 63
CA - Canada 59
AR - Argentina 46
BE - Belgio 38
TR - Turchia 34
MX - Messico 33
IQ - Iraq 32
ZA - Sudafrica 31
SA - Arabia Saudita 25
NL - Olanda 24
PK - Pakistan 24
EC - Ecuador 23
JP - Giappone 22
VE - Venezuela 21
CI - Costa d'Avorio 20
PL - Polonia 19
CL - Cile 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
CO - Colombia 15
MA - Marocco 15
ES - Italia 13
IE - Irlanda 12
IR - Iran 10
LT - Lituania 10
NP - Nepal 10
PH - Filippine 10
PY - Paraguay 10
TN - Tunisia 10
KE - Kenya 9
MY - Malesia 9
EG - Egitto 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
CR - Costa Rica 7
PE - Perù 7
ET - Etiopia 6
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
DZ - Algeria 5
JO - Giordania 5
PA - Panama 5
PS - Palestinian Territory 5
TW - Taiwan 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
CH - Svizzera 4
KG - Kirghizistan 4
OM - Oman 4
RO - Romania 4
AM - Armenia 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
LV - Lettonia 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
DM - Dominica 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AZ - Azerbaigian 1
BB - Barbados 1
CY - Cipro 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
Totale 13.343
Città #
Singapore 758
Fairfield 739
Ashburn 668
Woodbridge 567
Chandler 439
San Jose 412
Hong Kong 392
Houston 390
Jacksonville 378
Cambridge 316
Seattle 292
Dallas 276
Nyköping 247
Wilmington 241
Ann Arbor 232
Beijing 187
Lauterbourg 116
Bari 115
Lawrence 104
Roxbury 103
New York 102
Los Angeles 93
Nanjing 89
Princeton 82
Ho Chi Minh City 66
Des Moines 65
Helsinki 62
Inglewood 60
Council Bluffs 57
São Paulo 52
Boardman 49
Hanoi 43
Jakarta 42
Santa Clara 41
Brussels 37
Buffalo 36
Jiaxing 36
San Diego 36
Munich 34
Nanchang 32
Milan 30
Dong Ket 27
Falkenstein 27
Hebei 27
Shenyang 27
London 24
Brooklyn 22
Chicago 22
Rio de Janeiro 22
Frankfurt am Main 21
Toronto 21
Abidjan 20
Falls Church 20
Tokyo 20
Turku 20
Moscow 19
Brasília 18
Johannesburg 17
The Dalles 17
Warsaw 17
Belo Horizonte 16
Changsha 16
Dearborn 16
Guangzhou 16
Nuremberg 16
Paris 16
Shanghai 16
Brno 15
Columbus 15
Montreal 15
Orem 15
Tashkent 15
Atlanta 14
Baghdad 14
Dhaka 14
Pune 14
Mexico City 13
Biên Hòa 12
Chennai 12
Denver 12
Dublin 12
Jeddah 12
Phoenix 12
San Mateo 12
Tianjin 11
Augusta 10
Haiphong 10
Manchester 10
Stockholm 10
Zhengzhou 10
Genova 9
Hefei 9
Istanbul 9
Monmouth Junction 9
Poplar 9
Redwood City 9
Santiago 9
Taranto 9
Washington 9
Ankara 8
Totale 9.014
Nome #
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 235
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 227
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles 200
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin 198
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 198
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 197
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 195
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 187
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 185
Activation and inhibition of kidney CLC-K chloride channels by fenamates 184
Ion channels in drug discovery and safety pharmacology 175
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 173
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse 164
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 150
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 149
Antioxidant treatment of hindlimb-unloaded mouse in vivo counteracts fiber type transition but not atrophy of disused skeletal muscles 137
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice 137
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 137
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives 134
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels 133
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone 133
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness 133
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 133
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1 131
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 128
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse 127
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile 127
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 127
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 127
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 126
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium 126
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression 123
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 123
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia 122
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle 120
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ 120
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels 119
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 119
Taurine and skeletal muscle ion channels 118
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 118
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo 116
Age-dependent effects of disuse on electrophysiogical parameters and calcium homeostasis in the soleus muscle of hindlimb-unloaded mice 116
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 116
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 112
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 111
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 111
Taurine and skeletal muscle disorders 110
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 109
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 109
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 108
Pharmacology of CLC chloride channels and transporters 107
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 106
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 106
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 106
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 105
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels 104
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 103
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 102
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 101
Investigating a Benzofurane Derivative Binding Site on Human CLC-5 100
Effect of rat hindlimb suspension on cable properties, ionic conductances and fiber type composition of slow-twitch muscle. 100
null 100
Protein Kinase C-Theta Controls the CLC-1 Chloride Channel Function and Skeletal Muscle Phenotype: A Biophysical and Gene Expression Study in Pkc-Theta Null Mice 98
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 98
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 97
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 97
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat 96
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance 96
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 95
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers 95
Comparison of excitability parameters and sodium channel behavior of fast- and slow-twitch rat skeletal muscles for the study of the effects of hindlimb suspension, a model of hypogravity. 94
Molecular determinants of 2(p-chlorophenoxy)propionic acid for modulation of the native chloride channel conductance of rat skeletal muscle 94
Taurine and skeletal muscle ion channels 94
null 93
Therapeutic approaches to ion channel diseases 92
Potential targets for skeletal muscle impairment by hypogravity: basic characterization of resting ionic conductances and mechanical threshold of rat fast- and slow-twitch muscle fibers 92
Mechanisms of block of muscle type CLC chloride channels 92
An olive oil–derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 91
null 90
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels 87
null 87
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle 86
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 86
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 84
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 83
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 82
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 82
Potent and stereoselective use-dependent block of skeletal muscle Na+ channels by a new proline-like tocainide derivative 82
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB) 79
Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease 78
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 77
Potent effect of chiral derivative of mexiletine on rat skeletal muscle sodium channel 77
Brugada Syndrome: More than a Monogenic Channelopathy 76
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: Outcome of a large array of in vivo and ex vivo tests 75
Taurine ameliorates in vitro and in vivo the electrical and contractile properties of skeletal muscle fibres of dystrophic mdx mouse 74
Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach 74
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 73
Inflammatory pathways and dystrophic progression: effect of in vivo treatment with either target-specific or wide-acting drugs on functional, biochemical and histological markers of muscle damage in exercised mdx mice 72
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ. 71
Niflumic acid derivatives modulate macroscopic chloride conductance of native rat skeletal muscle by inhibiting the CLC-1 channel and by increasing the intracellular calcium level 70
Totale 11.612
Categoria #
all - tutte 57.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 0 0 78
2021/2022867 42 143 10 32 42 63 48 37 56 57 131 206
2022/20231.252 200 113 93 91 125 186 13 147 192 17 36 39
2023/2024494 31 79 26 64 50 106 24 20 5 36 7 46
2024/20252.244 81 37 153 75 77 217 215 208 86 119 297 679
2025/20264.563 639 249 446 484 538 238 597 143 560 470 192 7
Totale 13.743